Type I autoimmune hepatitis is primarily a disease of later life

QJM: An International Journal of Medicine

Volumn 90, Issue 4, 1997, Pages 289-296

  Parker, D R ^a   Kingham, J G C ^b  

^a MORRISTON HOSPITAL   (United Kingdom)

^b SINGLETON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE DURATION; ESOPHAGUS VARICES BLEEDING; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER NECROSIS; MALE; MORTALITY; ONSET AGE; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; SURVIVAL RATE; TREATMENT FAILURE; UNITED KINGDOM;

EID: 0030933077     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.4.289     Document Type: Article

References (23)

1. Waldenström J. Leber, Bluproteine und Nahrungsweiss Stoffwechs Krh, Sonderband: XV, p.8 Tatung, Bad Kissingen, 1950.
2. Kunkel HG, Ahrens EH, Eisenmenger WJ, Bongiovanni AM, Slater RJ. Extreme hypergammaglobulinaemia in young women with liver disease. J Clin Invest 1951; 30:654.
3. Beam AG, Kunkel HG, Slater RJ. The problem of chronic liver disease in young women. Am J Med 1956; 21:3.
4. Mackay IR, Taft LI, Cowling DC. Lupoid hepatitis. Lancet 1956; 2:1323-6.
5. Whittingham S, Mackay IR, Irwin J. Autoimmune hepatitis: immunofluorescence reactions with cytoplasm of smooth muscle and glomerular cells. Lancet 1966; 1:1333-5.
6. Whittingham S, Irwin J, Mackay IR, Smalley M. Smooth muscle autoantibody in 'autoimmune' hepatitis. Gastroenterology 1966; 51:499-505.
7. Doniach D, Roitt IM, Walker JG, Sherlock S. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol 1966; 1:237-62.
8. Hall S, Czaja AJ, Kaufman DK, Markowitz H, Ginsburg WW. How lupoid is lupus hepatitis? J Rheumatol 1986; 13:95-8.
9. Johnson PJ, McFarlane IG. Meeting report: International autoimmune hepatitis group. Hepatology 1993; 18:998-1005.
10. Czaja A, Carpenter HA. Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci 1996; 41:305-14.
11. Homberg J-C, Abauf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, Darnis F, Levy V-G, Grippon P, Opolon P, Bernau J, Benhamou J-P, Alagille D. Chronic active hepatitis associated with anti-liver/kidney microsome antibody type 1: a second type of 'autoimmune' hepatitis. Hepatology 1987; 7:1333-9.
12. Kirkwood BR. Survival analysis. In: Kirkwood BR. Essentials of Medical Statistics. Oxford, Blackwell Scientific, 1988:118-23.
13. Keating JJ, O'Brien CJ, Stellon AJ, Johnson PJ, Williams R. Influence of aetiology, clinical and histological features on survival in chronic active hepatitis: an analysis of 204 patients. Q J Med 1987; 237:59-66.
14. Sherlock S, Dooley J. Chronic autoimmune hepatitis. In: Diseases of the liver and biliary system, 9th edn. Oxford, Blackwell, 1993:299-306.
15. Read AE, Sherlock S, Harrison CV. Active juvenile cirrhosis considered as part of a systemic disease and the effect of corticosteroid therapy. Gut 1963; 4:378-93.
16. Johnson PJ, Eddleston ALWF. Autoimmune hepatitis. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine, 3rd edn. Oxford, Oxford University Press, 1996:2069-73.
17. Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 1971; 40:159-85.
18. Roberts SK, Thernau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996; 110:848-57.
19. Murray-Lyon IM, Stern RB, Williams R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet 1973; 1:735-7.
20. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995; 333:958-63.
21. Meyer zum Büschenfelde K-H, Lohse AW. Autoimmune hepatitis. N Engl J Med 1995; 333:1004-5.
22. Nikias GA, Batts KP, Czaja AJ. The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol 1994; 21:866-71.
23. Kirk AP, Jain S, Pocock S, Thomas IIC, Sherlock S. Late results of Royal Free Hospital controlled trial of prednisolone therapy in hepatitis B surface antigen-negative chronic active hepatitis. Gut 1980; 21:78-83.